On June 30th, BEKE-W (02423) spent 6.997 million US dollars to repurchase 1.178 million shares.
Shell-W (02423) announced that it will spend $6,997,000 to repurchase shares on June 30, 2025.
BEKE-W (02423) announced on June 30, 2025 that it will spend $6.997 million to repurchase 1.178 million shares of stock, at a repurchase price of $5.88-6.06 per share.
Related Articles
Ningbo Sanxing Medical Electric's subsidiary is expected to win a bid of 306 million yuan for a Southern Power Grid tender project.
Beijing Foyou Pharma (601089.SH): Benidipine Hydrochloride Tablets Obtained Drug Registration Certificate.
Beijing Foyou Pharma (601089.SH): Libenzocaine cream has obtained drug registration certificate.
Ningbo Sanxing Medical Electric's subsidiary is expected to win a bid of 306 million yuan for a Southern Power Grid tender project.
Beijing Foyou Pharma (601089.SH): Benidipine Hydrochloride Tablets Obtained Drug Registration Certificate.
Beijing Foyou Pharma (601089.SH): Libenzocaine cream has obtained drug registration certificate.
